Protein Expression Market: Growth, Size, Share, and Trends

Report Code BT 2435
Published in Nov, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Protein Expression Market by Product (Reagents, Vectors, Competent Cells, Instruments, Software), Services, System Type (Mammalian (CHO, HEK293), Insect, Yeast), Workflow, Application (Therapeutic, Research, Industrial) - Global Forecast to 2029

Overview

The protein expression market is expected to reach USD 4.82 billion in 2029 from USD 3.41 billion in 2024 at a CAGR of 7.1% during the forecast period. The increasing demand for biologics such as monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and vaccines, supported by the rise in R&D within the pharmaceutical & biopharmaceutical industries and the growing use of artificial intelligence and machine learning to enhance protein-based studies are some of the factors supporting the growth of this market. Moreover, there has been an increase in the development of personalized/ precision medicines in the past few years. The growing trend in the outsourcing of clinical research further propels the growth of the market. In addition, the growing focus on adopting plant-based and cell-free expression systems and advancements in synthetic protein production technologies can be viewed as opportunity areas. Major players in this market are also expanding their geographic presence by establishing manufacturing and research facilities in emerging economies.

Attractive Opportunities in the Protein Expression Market

Asia Pacific

The growth of the North American protein expression market is primarily due to the presence of major protein expression offering suppliers and consumers in the region, supported by increasing funding and investments in the development of protein-based therapies.

Growth in this market is primarily driven by the increasing demand for biologics supported by the rise in R&D within the pharmaceutical & biopharmaceutical industries and the growing use of artificial intelligence and machine learning to enhance the protein expression workflow.

The growing emphasis on the development of plant-based and cell-free expression systems for sustainable and cost-effective protein expression and the advancement in synthetic protein production technologies are likely to offer potential growth opportunities in the market.

The rise in the protein expression market in the Asia Pacific region is supported by the growing trend of outsourcing various clinical activities, such as drug research and development.

Factors such as the high cost of protein expression offerings and the renewed focus on small molecules in drug development pose a challenge to the growth of this market.

Global Protein Expression Market Dynamics

DRIVER: Increasing demand for biologics

The increasing development of protein therapeutics, such as monoclonal antibodies and antibody-drug conjugates, is a key factor in the expansion of the protein expression market. Biologics are often utilized to treat cancer, autoimmune diseases, and chronic inflammatory diseases. Regulatory authorities worldwide have been approving biologics for commercial use, supporting the growth in the protein expression market. 17 new biologics received approval from the US FDA in 2023, 12 of which were monoclonal antibodies. There has been a growing demand for high-performance protein expression systems to support the large-scale manufacturing of these therapeutic products. Moreover, the rise in the Biologics License Application (BLA) approvals supports a growing biologics market, further enhancing the adoption of advanced protein expression systems. Unmet therapeutic needs for various diseases are supporting novel treatment development, thus supporting the protein expression market.

RESTRAINT: Renewed focus on small molecules in drug development

The pharmaceutical industry has focused its attention on the research and development of small molecule-based drugs, which are slowing the growth of biologics and affecting the development of the protein expression market. Small molecules are preferred as they are more affordable, easier to administer, and have broader applications in therapies. In 2023, the US FDA approved 55 new drugs, of which over half were small molecules. This highlighted a strong focus by the industry on these drug modalities. Such a strong preference toward the research on small-molecule drugs can limit R&D investments in biologics, limiting the growth in the protein expression market.

 

OPPORTUNITY: Growing emphasis on plant-based and cell-free expression systems

The protein expression market presents various growth opportunities for companies operating in this market owing to the growing focus on developing and using plant-based and cell-free expression systems as an alternative to traditional mammalian and bacterial protein expression systems. Though traditional protein expression systems have constituted much of the biomanufacturing of many recombinant therapeutic and industrial proteins, they also pose several challenges in terms of their scalability and protein folding. The adoption of plant-based and cell-free protein expression (CFPE) methods is increasing due to their higher efficiencies and scalability at lower costs. Plant-based systems are easier to scale by increasing plant cultivation, leading to lower infrastructure costs and a faster production timeline. These systems consume less energy, recycle water, and produce less waste, and thus, are environmentally sustainable. Cell-free expression methods produce proteins outside living cells and improve flexibility and yield, especially for complex proteins requiring post-translational modifications. Platforms such as Alice by LenioBio GmbH (Germany) have demonstrated the ability of cell-free expression systems to produce proteins at large scales with high precision.

CHALLENGES: Production cost and efficiency issues

A major challenge in the protein expression market is the high production cost and efficiency issues associated with various protein expression systems designed for production. Bacterial systems, while inexpensive and high-yielding, typically produce inclusion bodies and insoluble aggregates of proteins that complicate purification and reduce yield. These systems lack the machinery for post-translational modifications required for proper protein function. Yeast systems can perform partial modification of the protein products. The high production costs and challenges in maintaining desired conditions for amplification are major hurdles faced while using these systems. The mammalian systems are more suitable for complex proteins but incur higher production and labor costs. These systems relatively exhibit lower expression levels than those in both bacterial and yeast systems. Additionally, plant-based systems have problems regarding the spread of recombinant genes and proteins into the food chain, limiting their adoption. These system-specific problems, combined with difficulties in low-cost commercial scalability and downstream processing, challenge large-scale protein manufacturing.

Global Protein Expression Market Ecosystem Analysis

The ecosystem for protein expression offerings comprises major life science companies offering protein expression products and services, regulatory authorities, and end users, such as academic & research institutes, CROs & CDMOs, pharmaceutical & biotechnology companies, and other end users. These stakeholders interact and collaborate to drive the advancement of protein expression solutions.

 

The extraction, purification, and characterization segment held the largest market share in the protein expression market, by workflow, in 2023.

Based on the workflow, the protein expression market is segmented into three phases, namely, cloning & transfection, transcription, translation, & post-translational modification (PTM), and extraction, purification, and characterization. The extraction, purification, & characterization segment held the largest market share of the protein expression market by workflow in 2023. This is the final stage of the protein expression workflow and involves steps such as isolation, purification, and verification of the properties of the expressed proteins. This phase involves the use of various extraction and purification instruments and specialized reagents that are generally expensive, leading to a large share of this segment.

The pharmaceutical & biotechnology companies led the protein expression products market, by end user in 2023.

Based on various end users utilizing protein expression products, the market is segmented into pharmaceuticals & biotechnology companies, academic research institutes, CROS & CDMOs, and other end users. In 2023, the pharmaceutical & biotechnology companies segment accounted for the largest share of the protein expression products market by end user. This large share is supported by the rising approval and use of therapeutic protein-based drugs, like monoclonal antibodies and vaccines. This has increased the need for efficient protein expression products from pharmaceutical and biotech companies, driving market growth. Additionally, the rising prevalence of chronic diseases worldwide has led to an increase in R&D investments for developing new therapies, further increasing demand for protein expression products.

North America was the dominant region in the protein expression market in 2023.

The North American protein expression market emerged as the largest protein expression market in 2023, which is expected to remain the same during the forecast period. The large share of this regional market is supported by the presence of major pharmaceutical and biotechnology companies actively focusing on developing novel protein-based therapies. The presence of prominent academic and research institutions has also supported the large share of this market. Moreover, the rising prevalence of chronic disorders, such as cancer and autoimmune diseases, and increased investments and funding in protein-based therapeutics research in the region further boost the market of protein expression offerings in the region.

HIGHEST CAGR MARKET IN 2024-2029
US FASTEST GROWING MARKET IN THE REGION

Recent Developments of Protein Expression Market

  • In June 2024, Thermo Fisher Scientific, Inc. (US) launched the Thermo Scientific Stellar mass spectrometer (MS), offering high throughput operations supporting translational omics research.
  • In July 2024, Thermo Fisher Scientific, Inc. (US) acquired Olink Holding AB (Sweden) to enhance its mass spectrometry and life science offerings.
  • In August 2024, Merck KGaA (Germany) acquired Mirus Bio (US) to improve its viral vector manufacturing capabilities and strengthen its bioprocessing portfolio by integrating the latter’s advanced transfection reagents.
  • In July 2024, Merck KGaA (Germany) launched its first GMP-compliant cell culture media (CCM) manufacturing facility in its life science center in Nantong, China.

Key Market Players

Want to explore hidden markets that can drive new revenue in Protein Expression Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered System Type, Offerings, Workflow, Application, Product End user, Service End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Questions Addressed by the Report

What are the opportunities for growth in the protein expression industry?
The growing use of plant-based and cell-free expression systems for efficient protein production, along with advancements in synthetic protein technologies, offer new growth opportunities in the protein expression market.
Which protein expression system dominated the protein expression market in 2023?
Mammalian protein expression held the largest share in the protein expression market in 2023. This segment dominated the market owing to the ability of mammalian expression systems to produce human-therapeutic proteins.
Which application segment of the protein expression market is expected to witness the highest growth during the forecast period?
During the forecast period, the research applications segment is expected to register the highest growth owing to an increase in protein expression research supported by rising government funding and grants.
Which end-user segment is expected to witness the highest growth in the protein expression products market?
The CROs and CDMOs segment is projected to experience the highest growth rate during the forecast period, supported by the growing trend of outsourcing clinical activities such as drug discovery and development.
What is the market size for the protein expression market?
The global protein expression market is estimated to reach USD 4.82 billion by 2029, growing at a CAGR of 7.1% during the forecast period.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Protein Expression Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
45
RESEARCH METHODOLOGY
49
EXECUTIVE SUMMARY
61
PREMIUM INSIGHTS
65
MARKET OVERVIEW
68
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Diverse applications of synthetic biology
    - Surging demand for bio-based products
    - Advancements in synthetic biology
    - Increasing funding in R&D and collaborations
    RESTRAINTS
    - Production scalability
    - Ethical and regulatory challenges
    OPPORTUNITIES
    - Rising opportunities for agricultural synthetic biology
    - Growing integration of artificial intelligence and machine learning
    CHALLENGES
    - Cost constraints
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    PRODUCT/SERVICE PROVIDERS
    END USERS
    REGULATORY LANDSCAPE
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - DNA synthesis and sequencing
    - Gene editing tools
    - Bioinformatics and computational tools
    - Nanotechnology
    COMPLEMENTARY TECHNOLOGIES
    - Cellular and tissue engineering
    ADJACENT TECHNOLOGIES
    - Metabolic engineering
  • 5.7 PATENT ANALYSIS
    METHODOLOGY
    NUMBER OF PATENTS FILED
    INNOVATION AND PATENT APPLICATIONS
  • 5.8 PRICING ANALYSIS
    INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER
    INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION
  • 5.9 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.10 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.11 INVESTMENT & FUNDING SCENARIO
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY BUYING CRITERIA
  • 5.14 IMPACT OF AI ON SYNTHETIC BIOLOGY MARKET
SYNTHETIC BIOLOGY MARKET, BY TOOL
104
  • 6.1 INTRODUCTION
  • 6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
    SURGING DEMAND FOR SYNTHETIC GENES TO SUPPORT MARKET GROWTH
  • 6.3 ENZYMES
    WIDE POTENTIAL OF ENZYME ENGINEERING IN OMICS STUDIES TO PROPEL MARKET
  • 6.4 CLONING TECHNOLOGY KITS
    ALTERATION AND OPTIMIZATION OF GENETIC CIRCUIT DESIGNS BY MOLECULAR BIOLOGY TECHNIQUES TO DRIVE MARKET
  • 6.5 SYNTHETIC CELLS
    GROWING POPULARITY OF SYNTHETIC CELLS AS SUBSTITUTES FOR NATURAL CELLS TO BOOST MARKET GROWTH
  • 6.6 CHASSIS ORGANISMS
    INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET
  • 6.7 XENO NUCLEIC ACIDS
    SPIKE IN DEMAND FOR BREAKTHROUGH MEDICINES TO AID MARKET GROWTH
SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY
128
  • 7.1 INTRODUCTION
  • 7.2 GENE SYNTHESIS
    RISING DEMAND FOR SYNTHETIC GENES AND INCREASING COMPETITIVENESS AMONG MARKET PLAYERS TO SPUR MARKET GROWTH
  • 7.3 GENOME ENGINEERING
    SURGING NEED FOR RAPID, CHEAP, AND MULTIPLEX MODIFICATION OF GENOMES TO DRIVE MARKET
  • 7.4 SEQUENCING
    RISING ADOPTION OF SEQUENCING TECHNOLOGY TO BOOST MARKET GROWTH
  • 7.5 BIOINFORMATICS
    INCREASING ADVANCEMENTS AND RISING USE OF BIOINFORMATICS TO PROPEL MARKET GROWTH
  • 7.6 CLONING
    PRECISE GENETIC REPLICATION TO ACCELERATE RESEARCH AND SCALING APPLICATIONS ACROSS VARIOUS INDUSTRIES
  • 7.7 SITE-DIRECTED MUTAGENESIS
    WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET
  • 7.8 MEASUREMENT & MODELING
    INCREASING DEMAND FOR CELL-FREE SYNTHETIC BIOLOGY TO FOSTER MARKET GROWTH
  • 7.9 MICROFLUIDICS
    RISING FOCUS ON INCREASING SCALABILITY OF SYNTHETIC BIOLOGY TOOLS TO PROPEL MARKET GROWTH
  • 7.10 NANOTECHNOLOGY
    CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY TO AID MARKET GROWTH
SYNTHETIC BIOLOGY MARKET, BY APPLICATION
163
  • 8.1 INTRODUCTION
  • 8.2 MEDICAL APPLICATIONS
    PHARMACEUTICALS
    - Potential of synthetic biology techniques in development of active pharmaceutical ingredients to drive market
    DRUG DISCOVERY & THERAPEUTICS
    - Cancer detection & diagnostics
    - Other drug discovery & therapeutic applications
    ARTIFICIAL TISSUE & TISSUE REGENERATION
    - Biosynthesis
    - Stem cell regulation
    - Other artificial tissue & tissue regeneration applications
  • 8.3 INDUSTRIAL APPLICATIONS
    BIOFUELS & RENEWABLE ENERGY
    - Advantages of using genetically engineered organisms for synthetic production of biofuels to propel market growth
    INDUSTRIAL ENZYMES
    - Textile industry
    - Paper industry
    - Consumer care industry
    - Other industries
    BIOMATERIALS & GREEN CHEMICALS
    - Production of green chemicals through microbial fermentation to drive market
  • 8.4 FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
    FLAVORS & FRAGRANCES
    - Rising demand for natural, sustainable products to bolster market growth
    OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
  • 8.5 ENVIRONMENTAL APPLICATIONS
    BIOREMEDIATION
    - Increasing need for cost-effective, on-site environmental monitoring methods to boost market
    BIOSENSING
    - Growing interest in development of whole-cell biosensors to drive market
SYNTHETIC BIOLOGY MARKET, BY REGION
257
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - Rising investment in synthetic biology companies and surging demand for bio-based products to drive market
    CANADA
    - Strong research infrastructure and availability of funding to support market growth
  • 9.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    - Government initiatives and increasing funding to propel market growth
    UK
    - Increasing R&D expenditure to favor market growth
    FRANCE
    - Investments aimed at increasing research in various biomedical fields to augment market growth
    SWITZERLAND
    - Established biotech ecosystem, strong academic institutions, and favorable government policies to favor market growth
    DENMARK
    - Presence of third-largest commercial drug development pipeline in Europe to favor market growth
    ITALY
    - Increasing life sciences R&D funded by both public and private organizations to foster market
    SPAIN
    - Well-established network of research centers, universities, and hospitals to support market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    - Rising growth opportunities for pharmaceutical and biopharmaceutical companies to drive market
    JAPAN
    - Growing awareness of synthetic biology's importance and potential applications to accelerate market growth
    INDIA
    - Increasing R&D activities and government funding initiatives to bolster market growth
    AUSTRALIA
    - Increasing funding for synthetic biology research to accelerate market growth
    SOUTH KOREA
    - Increasing focus on developing biotechnology and pharmaceutical sectors to boost market
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Growing life sciences and pharmaceutical industry to fuel demand for synthetic biological products
    MEXICO
    - Increasing support for biotechnology infrastructure development to augment market growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST
    MIDDLE EAST: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - KSA
    - UAE
    - Rest of GCC countries
    REST OF MIDDLE EAST
  • 9.7 AFRICA
    AFRICA: MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
431
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SYNTHETIC BIOLOGY MARKET
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Tool footprint
    - Technology footprint
    - Application footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS, 2023
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
452
  • 11.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    NOVOZYMES A/S
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/Services offered
    AGILENT TECHNOLOGIES INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    AMYRIS, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    CODEXIS, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    TWIST BIOSCIENCE
    - Business overview
    - Products/Services offered
    - Recent developments
    GENSCRIPT
    - Business overview
    - Products/Services offered
    - Recent developments
    PRECIGEN
    - Business overview
    - Products/Services offered
    GINKGO BIOWORKS
    - Business overview
    - Products/Services offered
    - Recent developments
    VIRIDOS
    - Business overview
    - Products/Services offered
    - Recent developments
    SYNTHEGO
    - Business overview
    - Products/Services offered
    - Recent developments
    CREATIVE ENZYMES
    - Business overview
    - Products/Services offered
    CYRUS BIOTECHNOLOGY
    - Business overview
    - Products/Services offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    ATUM
    TESELAGEN
    ARZEDA
    INTEGRATED DNA TECHNOLOGIES, INC.
    NEW ENGLAND BIOLABS
    ELEVATEBIO
    ZENFOLD (IOSYNTH)
    SYNBIO TECHNOLOGIES
    INSCRIPTA, INC.
    CRISPR THERAPEUTICS
APPENDIX
527
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 SYNTHETIC BIOLOGY MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 4 KEY END USERS IN SYNTHETIC BIOLOGY MARKET
  • TABLE 5 KEY REGULATORY BODIES IN SYNTHETIC BIOLOGY MARKET
  • TABLE 6 NUMBER OF PATENTS FILED IN SYNTHETIC BIOLOGY MARKET, BY DOCUMENT TYPE, 2014–2024
  • TABLE 7 DETAILED ANALYSIS OF KEY PATENTS IN SYNTHETIC BIOLOGY MARKET, 2024
  • TABLE 8 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER, 2023
  • TABLE 9 INDICATIVE PRICING ANALYSIS OF SYNTHETIC BIOLOGY TOOLS, BY REGION, 2023
  • TABLE 10 KEY CONFERENCES & EVENTS, JUNE 2024–DECEMBER 2025
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
  • TABLE 17 SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • TABLE 19 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 20 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 21 SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 22 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 23 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 25 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 64 SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 SYNTHETIC BIOLOGY MARKET FOR CLONING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 128 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 167 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 174 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 175 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 181 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 188 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 206 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 210 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 211 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 218 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 225 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 233 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 234 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 241 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 246 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 247 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 248 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 251 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 253 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 254 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 255 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 257 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 258 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 260 SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 261 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 262 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 264 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 265 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 267 SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 269 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 270 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 272 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 275 SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 276 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 277 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 278 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 280 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 282 SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 283 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 285 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 287 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 288 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 289 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 291 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 292 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 295 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 296 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 297 SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 298 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 299 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 301 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 302 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 303 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 304 SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 305 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 306 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 308 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 309 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 310 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 311 SYNTHETIC BIOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 312 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 313 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 314 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 315 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 316 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 319 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 321 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 NORTH AMERICA: KEY MACRO INDICATORS
  • TABLE 325 US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 326 US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 327 US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 328 US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 331 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 333 US: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 US: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 337 CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 338 CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 339 CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 340 CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 341 CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 343 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 344 CANADA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 CANADA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 348 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 349 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 350 EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 351 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 353 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 354 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 356 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 EUROPE: KEY MACRO INDICATORS
  • TABLE 360 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 361 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 362 GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 363 GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 365 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 366 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 367 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 368 GERMANY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 GERMANY: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 372 UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 373 UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 374 UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 375 UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 378 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 379 UK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 380 UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 381 UK: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 382 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 383 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 384 FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 385 FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 386 FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 387 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 388 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 389 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 390 FRANCE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 391 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 392 FRANCE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 393 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 394 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 395 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 396 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 397 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 400 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 401 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 402 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 403 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 405 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 406 DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 407 DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 412 DENMARK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 DENMARK: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 415 ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 416 ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 417 ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 418 ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 421 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 422 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 423 ITALY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 424 ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 425 ITALY: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 426 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 427 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 428 SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 429 SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 430 SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 432 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 433 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 434 SPAIN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 436 SPAIN: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 437 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 438 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 439 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 440 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 441 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 442 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 445 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 446 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 448 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 449 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 450 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 451 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 452 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 453 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 454 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 455 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 456 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 457 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 458 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 ASIA PACIFIC: KEY MACRO INDICATORS
  • TABLE 461 CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 462 CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 463 CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 464 CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 465 CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 466 CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 467 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 468 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 469 CHINA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 470 CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 471 CHINA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 472 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 473 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 474 JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 475 JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 477 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 478 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 480 JAPAN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 481 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 JAPAN: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 483 INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 484 INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 485 INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 486 INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 487 INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 488 INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 489 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 490 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 491 INDIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 492 INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 493 INDIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 495 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 496 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 497 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 498 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 499 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 500 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 501 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 502 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 503 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 505 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 506 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 507 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 508 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 511 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 512 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 513 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 516 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 517 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 518 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 519 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 522 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 523 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 524 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 525 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 526 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 527 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 528 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 529 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 530 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 531 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 532 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 534 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 535 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 536 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 537 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 538 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 539 LATIN AMERICA: KEY MACRO INDICATORS
  • TABLE 540 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 541 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 542 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 543 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 544 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 545 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 546 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 547 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 548 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 549 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 550 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 551 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 552 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 553 MEXICO: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 554 MEXICO: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 555 MEXICO: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 556 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 557 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 558 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 559 MEXICO: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 560 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 561 MEXICO: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 562 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 563 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 564 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 565 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 566 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 567 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 568 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 569 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 570 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 571 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 572 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 573 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION)
  • TABLE 574 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 575 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 576 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 577 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 578 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 579 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 580 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 581 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 582 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 583 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 584 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 585 MIDDLE EAST: KEY MACROINDICATORS
  • TABLE 586 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 587 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 588 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 589 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 590 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 591 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 592 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 593 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 594 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 595 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 596 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 597 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 598 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 599 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 600 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 601 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 602 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 603 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 604 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 605 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 606 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 607 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 608 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 609 UAE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 610 UAE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 611 UAE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 612 UAE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 613 UAE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 614 UAE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 615 UAE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 616 UAE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 617 UAE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 618 UAE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 619 UAE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 620 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 621 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 622 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 623 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 624 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 625 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 626 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 627 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 628 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 629 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 630 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 631 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 632 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 633 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 634 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 635 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 636 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 637 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 638 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 639 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 640 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 641 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 642 AFRICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 643 AFRICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 644 AFRICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 645 AFRICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 646 AFRICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 647 AFRICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 648 AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 649 AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 650 AFRICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 651 AFRICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 652 AFRICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 653 MACROECONOMIC OUTLOOK FOR SYNTHETIC BIOLOGY MARKET IN AFRICA
  • TABLE 654 SYNTHETIC BIOLOGY MARKET: KEY DEVELOPMENTS OF MAJOR PLAYERS, 2021–2024
  • TABLE 655 SYNTHETIC BIOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 656 SYNTHETIC BIOLOGY MARKET: REGION FOOTPRINT
  • TABLE 657 SYNTHETIC BIOLOGY MARKET: TOOL FOOTPRINT
  • TABLE 658 SYNTHETIC BIOLOGY MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 659 SYNTHETIC BIOLOGY MARKET: APPLICATION FOOTPRINT
  • TABLE 660 SYNTHETIC BIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 661 SYNTHETIC BIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 662 SYNTHETIC BIOLOGY MARKET: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 663 SYNTHETIC BIOLOGY MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 664 SYNTHETIC BIOLOGY MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 665 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 666 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 667 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 668 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 669 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 670 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 671 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 672 MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 673 NOVOZYMES A/S: COMPANY OVERVIEW
  • TABLE 674 NOVOZYMES A/S: PRODUCTS/SERVICES OFFERED
  • TABLE 675 NOVOZYMES A/S: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 676 NOVOZYMES A/S: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 677 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 678 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 679 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 680 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 681 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 682 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 683 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 684 AMYRIS, INC.: COMPANY OVERVIEW
  • TABLE 685 AMYRIS, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 686 AMYRIS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 687 CODEXIS, INC.: COMPANY OVERVIEW
  • TABLE 688 CODEXIS, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 689 CODEXIS, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 690 CODEXIS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 691 CODEXIS, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 692 TWIST BIOSCIENCE: COMPANY OVERVIEW
  • TABLE 693 TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED
  • TABLE 694 TWIST BIOSCIENCE: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 695 TWIST BIOSCIENCE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 696 TWIST BIOSCIENCE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 697 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 698 GENSCRIPT: PRODUCTS/SERVICES OFFERED
  • TABLE 699 GENSCRIPT: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 700 GENSCRIPT: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 701 GENSCRIPT: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 702 PRECIGEN: COMPANY OVERVIEW
  • TABLE 703 PRECIGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 704 GINKGO BIOWORKS: COMPANY OVERVIEW
  • TABLE 705 GINKGO BIOWORKS: PRODUCTS/SERVICES OFFERED
  • TABLE 706 GINKGO BIOWORKS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 707 GINKGO BIOWORKS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 708 VIRIDOS: COMPANY OVERVIEW
  • TABLE 709 VIRIDOS: PRODUCTS/SERVICES OFFERED
  • TABLE 710 VIRIDOS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 711 VIRIDOS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 712 VIRIDOS: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 713 SYNTHEGO: COMPANY OVERVIEW
  • TABLE 714 SYNTHEGO: PRODUCTS/SERVICES OFFERED
  • TABLE 715 SYNTHEGO: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 716 SYNTHEGO: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 717 SYNTHEGO: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 718 CREATIVE ENZYMES: COMPANY OVERVIEW
  • TABLE 719 CREATIVE ENZYMES: PRODUCTS/SERVICES OFFERED
  • TABLE 720 CYRUS BIOTECHNOLOGY: COMPANY OVERVIEW
  • TABLE 721 CYRUS BIOTECHNOLOGY: PRODUCTS/SERVICES OFFERED
  • TABLE 722 CYRUS BIOTECHNOLOGY: DEALS, JANUARY 2021–SEPTEMBER 2024
LIST OF FIGURES
 
  • FIGURE 1 SYNTHETIC BIOLOGY MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARIES: SYNTHETIC BIOLOGY MARKET
  • FIGURE 4 SYNTHETIC BIOLOGY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 SYNTHETIC BIOLOGY MARKET: CAGR PROJECTION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF SYNTHETIC BIOLOGY MARKET (2024-2029)
  • FIGURE 15 ADVANCEMENTS IN SYNTHETIC BIOLOGY AND RISING DEMAND FOR BIO-BASED PRODUCTS TO DRIVE MARKET
  • FIGURE 16 MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 17 MEDICAL APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 19 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 21 SYNTHETIC BIOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 SYNTHETIC BIOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 SYNTHETIC BIOLOGY MARKET: PATENT ANALYSIS, 2013–2023
  • FIGURE 24 SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 27 NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET, 2019–2023 (USD MILLION)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET, 2023
  • FIGURE 31 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 32 SYNTHETIC BIOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 33 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 34 EV/EBITDA OF KEY VENDORS, 2023
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 36 SYNTHETIC BIOLOGY MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 39 NOVOZYMES A/S: COMPANY SNAPSHOT (2023)
  • FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 42 CODEXIS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 43 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)
  • FIGURE 44 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 45 PRECIGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 46 GINKGO BIOWORKS: COMPANY SNAPSHOT (2023)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global protein expression market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The market for the companies offering protein expression solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives. Secondary data was analyzed to arrive at the overall size of the global protein expression market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global protein expression market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic and research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (including Latin America, the Middle East, and Africa). Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

In the complete market engineering process, the top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the protein expression market was estimated and validated through multiple approaches such as the top-down and bottom-up approaches. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the protein expression business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Market Definition

The protein expression market encompasses the technologies, products, and services required for the production and analysis of recombinant proteins. This market includes various expression systems (mammalian, bacterial, yeast, algal, insect, and cell-free), reagents and instruments for transfection and cloning, growth reagents for cell culture during translation, and reagents and kits for downstream processes like purification and characterization. It serves industries like pharmaceuticals, biotechnology, academic research institutes, CROs & CDMOs, and other industrial users, supporting applications in drug discovery, therapeutic development, and biochemical research, as well as supporting other industries such as food and beverages, cosmetics, and textile among others.

Stakeholders

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Biotechnology Companies
  • Academic and Research Institutions
  • Clinical Research Laboratories
  • Pharmaceutical Companies
  • Diagnostic Companies
  • Food & Beverage Companies
  • Suppliers of Expression Systems
  • Protein Expression Instrument & Reagent Manufacturers
  • Regulatory Agencies

Report Objectives

  • To define, describe, and forecast the protein expression market based on system type, offerings, workflow, application, product end user, service end user, and region
  • To provide detailed information regarding the major factors influencing the market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall protein expression market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the revenue of the market segments with respect to six main regions, namely, North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Africa and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina and Rest of Latin America, the Middle East (GCC countries and rest of the Middle East) and Africa.
  • To profile the key market players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as product launches, agreements, partnerships, acquisitions, business expansions, and research & development activities in the protein expression market

Previous Versions of this Report

Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User & Region - Global Forecast to 2027

Report Code BT 2435
Published in Nov, 2024, By MarketsandMarkets™

Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027

Report Code BT 2435
Published in Oct, 2022, By MarketsandMarkets™

Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025

Report Code BT 2435
Published in May, 2020, By MarketsandMarkets™

Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022

Report Code BT 2435
Published in Jul, 2017, By MarketsandMarkets™

Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018

Report Code BT 2435
Published in Apr, 2014, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Protein Expression Market

DMCA.com Protection Status